DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model
<p>Aims: To explore the cost-effectiveness of alternative methods of screening family members for hypertrophic cardiomyopathy (HCM), the most common monogenic cardiac disorder and the most frequent cause of sudden cardiac death (SCD) in young people.</p><p>Methods and results: Econ...
المؤلفون الرئيسيون: | Wordsworth, S, Leal, J, Blair, E, Legood, R, Thomson, K, Seller, A, Taylor, J, Watkins, H |
---|---|
مؤلفون آخرون: | The European Society of Cardiology |
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Oxford University Press
2010
|
الموضوعات: |
مواد مشابهة
-
Is DNA testing for hypertrophic cardiomyopathy cost-effective?
حسب: Wordsworth, S, وآخرون
منشور في: (2006) -
DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.
حسب: Wordsworth, S, وآخرون
منشور في: (2010) -
The role of cardiac energy metabolism and during stress in hypertrophic and dilated cardiomyopathy.
حسب: Dass, S
منشور في: (2012) -
Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on Chromosome 17
حسب: Farrall, M, وآخرون
منشور في: (2006) -
Altered contractile mechanics and Ca2+ handling contribute to cardiomyopathy pathogenesis
حسب: Turtle, C
منشور في: (2015)